BioCentury
ARTICLE | Company News

University of Rochester, Panther Biotechnology deal

June 8, 2015 7:00 AM UTC

The university granted Panther exclusive, worldwide rights to develop and commercialize leukemia candidate TDZD-8. The kinase inhibitor induces oxidative stress and is in preclinical testing. Panther...